M28 Capital Management LP - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
M28 Capital Management LP ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,680,000
-17.1%
346,190
-35.0%
4.86%
-3.1%
Q1 2023$4,438,974
-0.4%
532,890
+10.4%
5.02%
+18.1%
Q4 2022$4,457,075
-33.6%
482,890
-7.6%
4.25%
-39.4%
Q3 2022$6,710,000
-3.6%
522,550
-0.9%
7.00%
-10.3%
Q2 2022$6,964,000
-37.2%
527,1500.0%7.81%
-23.5%
Q1 2022$11,097,000
-12.2%
527,1500.0%10.20%
+3.3%
Q4 2021$12,646,000527,1509.88%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 17,161,713$666,561,00074.20%
RTW INVESTMENTS, LP 3,644,248$141,543,0002.21%
Redmile Group, LLC 2,544,062$98,811,0001.39%
Cormorant Asset Management, LP 1,437,807$55,844,0001.24%
ACUTA CAPITAL PARTNERS, LLC 45,000$1,748,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 150,729$5,854,0000.45%
HighVista Strategies LLC 13,692$532,0000.40%
Birchview Capital, LP 15,000$583,0000.35%
Perceptive Advisors 671,978$26,100,0000.33%
GILDER GAGNON HOWE & CO LLC 1,265,950$49,169,0000.26%
View complete list of STOKE THERAPEUTICS INC shareholders